Skip to main content

Table 4 Liver function test, coagulation tests, and additional renal tests

From: A challenging case of COVID-19: a COVID-19 positive adolescent presented with severe diabetic ketoacidosis, resistant hypertension

  During admission Ref
AST U/L 18 7–55
ALT U/L 13 8–48
ALK-Ph U/L 636 40–129
Bili T. mg/dL 1.1 0.1–1.2
Bili D. mg/dl 0.5 <0.3
CPK U/L 81 39–308
LDH U/L 711 140–280
Alb g/dL 3.15 3.4–5.4
Amylase U/L 34 23–85
Lipase U/L 36 0–160
PT sec 13 10–13
PTT sec 27 25–36
INR 1 0.9–1.15
CL mmol/L 97.9 95–110
Anti-DNA IU/mL 1.2 < 30.0
C3 g/L 152 0.9–1.8
C4 g/L 57  
CH50 mg/dl 89.4 low:0–100
nl:101–300
hi > 301
ANA u/ml 0.7 neg. < 0.8
equ:0.8–1.2
pos. < 1.2
ANCA 0.6 neg .< 12
equ:12–18
pos. < 18
P ANCA 0.1
Urine24h,cr mg/24 h 575 800–2000
Urine24h,pro.mg/24 h 497
Urine24h,vol. ml 1150 600–2500
Urine24h,k meq/24 h 49.5 30–120